Latest AI and machine learning research in dementia for healthcare professionals.
BackgroundMild cognitive impairment is a prodromal stage of dementia, and early identification is cr...
This study introduces a deep learning framework for the inferential exploration of latent representa...
Mild Cognitive Impairment (MCI) involves cognitive decline beyond age-expected norms without impairi...
BACKGROUND: Hip fractures are a major global health issue with high mortality and morbidity, especia...
Loneliness and social isolation are important psychosocial concerns in dementia care, but they are d...
Alzheimer's Disease (AD) is a degenerative neurological condition characterized by memory loss, cogn...
Advances in voice recognition and artificial intelligence (AI) could soon yield digital conversation...
Facial analysis is increasingly being explored as a source of scalable behavioral signals relevant t...
INTRODUCTION: Identifying disease-modifying drug targets is crucial for developing effective Alzheim...
INTRODUCTION: Alzheimer's Disease (AD) affects more than 57 million people, yet drug development fac...
Glycogen Synthase Kinase-3 Beta is a multifunctional serine/threonine kinase, involved in regulating...
BACKGROUND: Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) co-occur frequently, and gr...
Dementia, a degenerative disease affecting millions globally, is projected to triple by 2050. Early ...
Alzheimer's disease (AD) is a highly heritable neurodegenerative disorder whose genetic architecture...
BACKGROUND: Cognitive impairment is the growing challenge that requires early diagnosis and personal...
Convolutional neural networks (CNNs) achieve high performance in electroencephalographic (EEG) class...
BACKGROUND: Identifying older home care recipients at risk of institutionalization in advance is cru...
There is a shortage of physicians trained in the specialized care of Alzheimer's disease (AD). One p...
PURPOSE: Assessing generalizability and performance of machine learning models in clinical settings ...
BACKGROUND: The global prevalence of dementia continues to rise and demands scalable, nonpharmacolog...
Accelerated brain aging is increasingly recognized as a transdiagnostic risk factor for neuropsychia...